Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, Offers Guidance

July 30, 2021 7:13 AM EDT
Get Alerts IRMD Hot Sheet
Price: $33.19 +0.51%

Today's EPS Names:
NEOG, AZO, ADBE, More
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $9.8 million versus the consensus estimate of $8.46 million.

GUIDANCE:

Iradimed Corp. sees Q3 2021 EPS of $0.16-$0.17, versus the consensus of $0.13. Iradimed Corp. sees Q3 2021 revenue of $10.3-10.5 million, versus the consensus of $9.4 million.

Iradimed Corp. sees FY2021 EPS of $0.60-$0.62, versus the consensus of $0.53. Iradimed Corp. sees FY2021 revenue of $40-40.4 million, versus the consensus of $37.5 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings